AstraZeneca
AZN
376 hedge funds and large institutions have $6.27B invested in AstraZeneca in 2015 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 136 increasing their positions, 111 reducing their positions, and 37 closing their positions.
185% more capital inflows, than outflows
Capital inflows: $905M | Capital outflows: $317M
35% more call options, than puts
Call options by funds: $107M | Put options by funds: $79.6M
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
23% more repeat investments, than reductions
Existing positions increased: 136 | Existing positions reduced: 111
0.68% more ownership
Funds ownership: 7.12% → 7.79% (+0.68%)
8% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 37
3% less funds holding
Funds holding: 386 → 376 (-10)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$166M |
| 2 |
Cambiar Investors
Denver,
Colorado
|
+$144M |
| 3 |
Camber Capital Management
Boston,
Massachusetts
|
+$85.6M |
| 4 |
Epoch Investment Partners
New York
|
+$72.1M |
| 5 |
Renaissance Technologies
New York
|
+$53.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$35.7M |
| 2 |
California Public Employees Retirement System
Sacramento,
California
|
-$28.8M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$25.8M |
| 4 |
Janney Capital Management
Pittsburgh,
Pennsylvania
|
-$23.6M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$22M |
AZN Hedge Fund Activity: Q2 2015 in Review
376 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q2 2015, worth a combined $6.27B — up 1.9% from $6.15B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of AZN and 34 opened new positions — a net loss of 3 holders — while 111 trimmed existing stakes and 136 added.
The largest buyer was Capital International Investors, adding an estimated $166M. The largest seller was Jane Street, exiting entirely with an estimated $35.7M sold.
- 376 institutional investors held AstraZeneca (AZN) as of Q2 2015, down from 386 in Q1 2015.
- Funds reported $6.27B of AstraZeneca stock for Q2 2015, up 1.9% quarter-over-quarter.
- 34 funds opened new AstraZeneca positions in Q2 2015 and 37 closed out, a net change of -3 holders.
- The largest AstraZeneca buyer in Q2 2015 was Capital International Investors, an estimated $166M added.
- The largest AstraZeneca seller in Q2 2015 was Jane Street, an estimated $35.7M sold.
Based on aggregated 13F filings for Q2 2015.